Alzheimer's patients are to get ADHD drugs in a trial backed by Andy Burnham, whose father died of the disease
Angela Bucksey, 67, from Cambridgeshire, is the first patient to begin treatment on the AD-SMART study, which opens with diabetes drug metformin and ADHD medicine atomoxetine. Experts expect the trial's design to cut testing time by more than half and save millions of pounds. Roy Burnham, a former telephone engineer, died last month aged 86 in a care home, never knowing his son had risen to become Prime Minister.
Every drug is measured against one shared placebo group, and any that fail can be dropped fast.
Andy Burnham said: 'I have made dementia research a national priority.'
Angela Bucksey on joining the trial: 'I will fight back.'
More
AOL News UKPioneering dementia trial will test diabetes and ADHD medicines against Alzheimer'sThe TelegraphADHD drug to be tested as Alzheimer’s treatmentThe IndependentADHD and diabetes drugs to be tested in pioneering Alzheimer’s studyLBCNew clinical trial backed by Andy Burnham could speed up Alzheimer’s treatmentsDaily MailHundreds of Alzheimer's patients to get ADHD drugsThe TimesADHD and diabetes drugs to be tested in Alzheimer’s clinical trialThe IndependentBurnham backs pioneering clinical trial that could speed up Alzheimer’s treatmentsThe MirrorAndy Burnham welcomes world-first dementia drug trial after dad Roy dies from the diseaseBBC News - HealthDiabetes and ADHD drugs to be tested on Alzheimer's patients in new study
